The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
TREM2 — a key player in microglial biology and Alzheimer disease
Abstract
Alzheimer disease (AD) is a debilitating dementia believed to result from the deposition of extracellular amyloid-β (Aβ)-containing plaques followed by the formation of neurofibrillary tangles. Familial AD typically results from mutations in the genes encoding amyloid precursor protein (APP), presenilin 1 or presenilin 2. Variations in triggering receptor expressed on myeloid cells 2 (TREM2), one of several genes for which expression is restricted to microglia in the brain, have now been shown to increase the risk of developing late-onset AD. Microglia have been shown to respond to Aβ accumulation and neurodegenerative lesions, progressively acquiring a unique transcriptional and functional signature and evolving into disease-associated microglia (DAM). DAM attenuate the progression of neurodegeneration in certain mouse models, but inappropriate DAM activation accelerates neurodegenerative disease in other models. TREM2 is essential for maintaining microglial metabolic fitness during stress events, enabling microglial progression to a fully mature DAM profile and ultimately sustaining the microglial response to Aβ-plaque-induced pathology. Here, we review the current data detailing the role of TREM2 in microglial biology and AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREM2 engagement with ligands triggers the phosphorylation of the DAP12 ITAM, subsequently initiating a cascade of activation of downstream kinases, such as AKT, MAPK, and mTOR29,30.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [30]
In the citing paper
“These kinases are centrally involved in controlling cell metabolism, survival, proliferation, and phagocytosis29,30.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [30]
In the citing paper
“TREM2 engagement leads to DAP12 phosphorylation, followed by recruitment and activation of the spleen-associated tyrosine kinase (SYK), resulting in downstream signaling events leading to proliferation, survival, phagocytosis, and secretion of cytokines and chemokines [47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“The general consensus is that TREM2 is expressed by microglia in the CNS, especially after activation [6, 21, 47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“TREM2 binds on the membrane to the DNAX-activation protein 12 (DAP12) which is an adaptor protein required for TREM2 surface expression and intracellular signaling [47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“In comparison to previous studies which are aligned to the concept that suppressing microglial function may be beneficial in the setting of AD [49], the data described here, together with studies on TREM2 and other AD-associated variants, suggest that a different directionality may be therapeutically useful [6, 46, 50].”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [46]
In the citing paper
“One receptor acting upstream of Plcg2 and evoking such responses in innate immune cells might be Trem2 [17, 46].”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [46]
In the citing paper
“TREM2 is one of the key receptors modulating PLCγ2 activity [12, 36, 37].”
From Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers (2026) · cites this paper as [36]
In the citing paper
“Although TREM2 is expressed on the cell surface, it is cleaved from the cell surface by metalloproteases and released as soluble TREM2 (sTREM2) (Ulland and Colonna, 2018).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“TREM2 has been extensively studied in microglia for its capacity to sustain microglial responses to neurodegenerative pathologies such as Alzheimer’s disease (Ulland and Colonna, 2018).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“This could be representative of changes in TREM2 expression or shedding, both of which are altered during ageing and disease [55], thereby reducing TREM2-mediated signalling and subsequent conversion of microglia to DAM [56].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [56]
In the citing paper
“Rac is known to be activated downstream of TREM2/DAP12 via Syk and Vav2/3 activation [56].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [56]
In the citing paper
“Mutations affecting the TREM2 function impair microglial activation (37) and reduce their ability to accumulate LDs in the AD brain (38).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [37]
In the citing paper
“Loss-of-function (LOF) variants of TREM2, an immune receptor expressed in microglia, increase Alzheimer’s disease risk.”
From TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“Certain TREM2 LOAD variants, including R47H, show reduced affinity to lipids”
From TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“Most notably, a hypomorphic variant in the microglial receptor TREM2, R47H, increases the risk of AD several fold, as do other TREM2 variants, such as R62H, although with reduced penetrance14.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [14]
In the citing paper
“AD patients carrying the R47H variant, who have a higher risk (2-4-fold) of developing AD than do R62H carriers.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [14]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Self-citation2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Research works printed but not linked: 3
- Nissl, F. in Histologische und histopathologische Arbeiten über die Grosshirnrinde Vol. 1 (eds. Nissl, F., Alzheimer, A.) 315–494 (G. Fischer, Jena, Germany, 1904).
- Alzheimer, A. in Histologische und histopathologische Arbeiten über die Grosshirnrinde Vol. 3 (eds. Nissl, F., Alzheimer, A.) 401–562 (G. Fischer, Jena, Germany, 1910).
- Hortega, P. R. El tercer elemento de los centros nerviosos. III. Naturaleza probable de la microglía [Spanish]. Bol. Soc. Esp. Biol. 8, 108–115 (1919).
Cited by
Sorted by citations
Items 101–200 of 737
Microglia Heterogeneity in Alzheimer’s Disease: Insights From Single-Cell Technologies
Wang, H. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.773590 · Cited by 62
Fang, C., Hernandez, P., Liow, K. K., Damiano, E., Zetterberg, H., Blennow, K., Feng, D., Chen, M., & Maccecchini, M. L. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.84 · Cited by 66
Cao, Y., Zhao, L.-W., Chen, Z.-X., & Li, S.-H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1430465 · Cited by 65
Reformulating Pro-Oxidant Microglia in Neurodegeneration
García‐Revilla, J., Alonso-Bellido, I. M., Burguillos, M. Á., Herrera, A. J., Espinosa‐Oliva, A. M., Ruiz, R., Cruz-Hernández, L., García-Domínguez, I., Roca-Ceballos, M. A., Santiago, M., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101719 · Cited by 66
Zhou, Y., Tada, M., Cai, Z., Andhey, P. S., Swain, A., Miller, K. R., Gilfillan, S., Artyomov, M. N., Takao, M., Kakita, A., et al. (2023) · Nature Immunology · doi:10.1038/s41590-022-01403-y · Cited by 62
Self-citationBeneficial Metabolic Effects of TREM2 in Obesity Are Uncoupled From Its Expression on Macrophages
Sharif, O., Brunner, J. S., Korosec, A., Martins, R., Jaïs, A., Snijder, B., Vogel, A., Caldera, M., Hladik, A., Lakovits, K., et al. (2021) · Diabetes · doi:10.2337/db20-0572 · Cited by 60
Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer’s disease
Choi, H., Choi, Y., Lee, E. J., Kim, H., Lee, Y., Kwon, S., Hwang, D. W., Lee, D. S., & Initiative, A. D. N. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02244-6 · Cited by 58
Exploring the Impact of TREM2 in Tumor-Associated Macrophages
Khantakova, D., Brioschi, S., & Molgora, M. (2022) · Vaccines · doi:10.3390/vaccines10060943 · Cited by 69
Fernando, K., & Wijayasinghe, Y. S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.746631 · Cited by 57
Hu, Y., & Tao, W. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.01.006 · Cited by 64
Metabolomics and lipidomics strategies in modern drug discovery and development
Astarita, G., Kelly, R. S., & Lasky-Su, J. A. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103751 · Cited by 63
Microglia Activation and Inflammation During the Death of Mammalian Photoreceptors
Karlen, S. J., Miller, E. B., & Burns, M. E. (2020) · Annual Review of Vision Science · doi:10.1146/annurev-vision-121219-081730 · Cited by 58
Turning enemies into allies—reprogramming tumor-associated macrophages for cancer therapy
Molgora, M., & Colonna, M. (2021) · Med · doi:10.1016/j.medj.2021.05.001 · Cited by 56
Self-citationMicroglial Immunometabolism in Alzheimer’s Disease
Shippy, D. C., & Ulland, T. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.563446 · Cited by 56
Self-citationYang, S., Qin, C., Chen, M., Chu, Y., Tang, Y., Zhou, L., Zhang, H., Dong, M., Pang, X., Chen, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202305614 · Cited by 57
Saeki, K., Pan, R., Lee, E., Kurotaki, D., & Ozato, K. (2024) · Nature Immunology · doi:10.1038/s41590-024-01962-2 · Cited by 55
LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00550-y · Cited by 54
Cosker, K., Mallach, A., Limaye, J., Piers, T. M., Staddon, J. M., Neame, S. J., Hardy, J., & Pocock, J. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-91207-1 · Cited by 53
Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy
Quan, M., Cao, S., Wang, Q., Wang, S., & Jia, J. (2023) · Phenomics · doi:10.1007/s43657-023-00098-x · Cited by 62
Reich, M., Paris, I., Ebeling, M., Dahm, N., Schweitzer, C., Reinhardt, D., Schmucki, R., Prasad, M., Köchl, F., Leist, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.617860 · Cited by 49
Yang, T., Velagapudi, R., Kong, C., Ko, U., Kumar, V., Brown, P., Franklin, N. O., Zhang, X., Caceres, A. I., Min, H., et al. (2022) · British Journal of Anaesthesia · doi:10.1016/j.bja.2022.05.025 · Cited by 55
Pan, L., Cho, K.-S., Wei, X., Xu, F., Lennikov, A., Hu, G., Tang, J., Guo, S., Chen, J., Kriukov, E., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112889 · Cited by 52
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
Balestri, W., Sharma, R., da Silva, V. A., Bobotis, B. C., Curle, A. J., Kothakota, V., Kalantarnia, F., Hangad, M. V., Hoorfar, M., Jones, J., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03024-8 · Cited by 55
Prefrontal cortex alterations in glia gene expression in schizophrenia with and without suicide
Zhang, L., Verwer, R. W. H., Lucassen, P. J., Huitinga, I., & Swaab, D. F. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.11.002 · Cited by 52
Direct and indirect effects of lipids on microglia function
Leyrolle, Q., Layé, S., & Nadjar, A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134348 · Cited by 50
TREM2 Overexpression Attenuates Cognitive Deficits in Experimental Models of Vascular Dementia
Wang, Q., Yang, W., Zhang, J., Zhao, Y., & Xu, Y. (2020) · Neural Plasticity · doi:10.1155/2020/8834275 · Cited by 52
A transcriptional toolbox for exploring peripheral neuroimmune interactions
Liang, Z., Hore, Z. L., Harley, P., Stanley, F. U., Michrowska, A., Dahiya, M., Russa, F. L., Jager, S. E., Villa‐Hernández, S., & Denk, F. (2020) · Pain · doi:10.1097/j.pain.0000000000001914 · Cited by 51
Berdowski, W. M., van der Linde, H. C., Breur, M., Oosterhof, N., Beerepoot, S., Sanderson, L. E., Wijnands, L. I., de Jong, P., Tsai-Meu-Chong, E., de Valk, W. G., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02440-5 · Cited by 52
Disease-associated microglia in neurodegenerative diseases: Friend or foe?
Cheng, Y.-H., & Ho, M. S.-C. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003426 · Cited by 57
Contribution of colony-stimulating factor 1 to neuropathic pain
Yu, X., Basbaum, A. I., & Guan, Z. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000883 · Cited by 47
The role of TREM2 in Alzheimer’s disease: from the perspective of Tau
Huang, W., Huang, J., Huang, N., & Luo, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1280257 · Cited by 49
“This transmits signals into the cell to enable microglia to play roles related to proliferation, phagocytosis, and in fl ammation (Ulland and Colonna, 2018).”
BackgroundHallmarks of neurodegenerative disease: A systems pharmacology perspective
Bloomingdale, P., Karelina, T., Ramakrishnan, V., Bakshi, S., Véronneau‐Veilleux, F., Moye, M., Sekiguchi, K., Meno‐Tetang, G. M. L., Mohan, A., Maithreye, R., et al. (2022) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12852 · Cited by 54
Knapskog, A., Henjum, K., Idland, A., Eldholm, R. S., Persson, K., Saltvedt, I. T., Watne, L. O., Engedal, K., & Nilsson, L. N. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-72878-8 · Cited by 53
The P2X7 receptor: a new therapeutic target in Alzheimer’s disease
Illés, P., Rubini, P., Huang, L., & Tang, Y. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1575811 · Cited by 50
The role of genetic risk factors of Alzheimer’s disease in synaptic dysfunction
Fu, W.-Y., & Ip, N. Y. (2023) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2022.07.011 · Cited by 48
Inflammation unites diverse acute and chronic diseases
Libby, P., Smith, R. D., Rubin, E. J., Glassberg, M. K., Farkouh, M. E., & Rosenson, R. S. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14280 · Cited by 57
Ma, Y., Hu, X., Karako, K., Song, P., Tang, W., & Xia, Y. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1576020 · Cited by 53
TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation
Moutinho, M., Coronel, I., Tsai, A. P., Di Prisco, G. V., Pennington, T., Atwood, B. K., Puntambekar, S. S., Smith, D. C., Martinez, P., Han, S., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01160-z · Cited by 42
“Genetic variants have been associated with an elevated risk of AD and other neurodegenerative diseases, and studies in animal models have uncovered the molecular mechanisms subserving the actions of this receptor [9, 10, 48].”
BackgroundTwo macrophages, osteoclasts and microglia: from development to pleiotropy
Lee, J., Lee, I., Iimura, T., & Kong, S. W. (2021) · Bone Research · doi:10.1038/s41413-020-00134-w · Cited by 46
Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity
Wang, Y., Guo, L., Yin, X., McCarthy, E. C., Cheng, M. I., Hoang, A. T., Chen, H.-C., Patel, A. Y., Trout, D. A., Xu, E., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114406119 · Cited by 44
Glial Cells as Regulators of Neuroimmune Interactions in the Central Nervous System
Antel, J. P., Becher, B., Ludwin, S. K., Prat, A., & Quintana, F. J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900908 · Cited by 46
Genetic Dissection of Alzheimer’s Disease Using Drosophila Models
Jeon, Y., Lee, J., Choi, B., Won, S.-Y., & Cho, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030884 · Cited by 46
Rong, Z., Cheng, B., Zhong, L., Ye, X., Li, X., Jia, L., Li, Y., Shue, F., Wang, N., Cheng, Y., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000550rr · Cited by 49
Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders
Golde, T. E. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.027 · Cited by 45
Sheng, Y., Hu, W., Chen, S., & Zhu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1275203 · Cited by 50
Singh, A. K., Mishra, G., Maurya, A., Awasthi, R., Kumari, K., Thakur, A., Rai, A., Rai, G. K., Sharma, B., Kulkarni, G. T., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190903102822 · Cited by 45
Peroxiredoxin 6 mediates protective function of astrocytes in Aβ proteostasis
Pankiewicz, J. E., Diaz, J. R., Martá-Ariza, M., Lizińczyk, A. M., Franco, L. A., & Sadowski, M. J. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00401-8 · Cited by 47
Long Non-coding RNA: Insight Into Mechanisms of Alzheimer's Disease
Lan, Z., Chen, Y., Jin, J., Xu, Y., & Zhu, X. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.821002 · Cited by 45
Zhao, P., Xu, Y., Fan, X., Li, L., Li, X., Arase, H., Tong, Q., Zhang, N., & An, Z. (2022) · mAbs · doi:10.1080/19420862.2022.2107971 · Cited by 46
Lordén, G., Wozniak, J. M., Doré, K., Dozier, L. E., Cates‐Gatto, C., Patrick, G. N., Gonzalez, D. J., Roberts, A. J., Tanzi, R. E., & Newton, A. C. (2022) · Nature Communications · doi:10.1038/s41467-022-34679-7 · Cited by 45
microRNA-132 regulates gene expression programs involved in microglial homeostasis
Walgrave, H., Penning, A., Tosoni, G., Snoeck, S., Davie, K., Davis, E., Wolfs, L., Sierksma, A., Mars, M., Bu, T., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106829 · Cited by 41
The Unfolded Protein Response in Immune Cells as an Emerging Regulator of Neuroinflammation
Fernández, D., Geisse, A., Bernales, J. I., Lira, A., & Osorio, F. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.682633 · Cited by 44
Pesämaa, I., Müller, S. A., Robinson, S., Darcher, A., Paquet, D., Zetterberg, H., Lichtenthaler, S. F., & Haass, C. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00657-w · Cited by 47
Dysregulated Brain Cholesterol Metabolism Is Linked to Neuroinflammation in Huntington's Disease
González‐Guevara, E., Cárdenas, G., Pérez‐Severiano, F., & Martínez‐Lazcano, J. C. (2020) · Movement Disorders · doi:10.1002/mds.28089 · Cited by 45
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?
Geladaris, A., Häusler, D., & Weber, M. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073461 · Cited by 44
Lan, L., Wang, H., Zhang, X., Shen, Q., Li, X., He, L., Rong, X., Peng, J., Mo, J., & Peng, Y. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114061 · Cited by 40
Das, M. M., Mao, W., Voskobiynyk, Y., Necula, D., Lew, I., Petersen, C., Zahn, A., Yu, G.-Q., Yu, X., Smith, N., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106263 · Cited by 41
Sarazin, M., Lagarde, J., Haddad, I., de Souza, L. C., Bellier, B., Potier, M., Bottlaender, M., & Dorothée, G. (2024) · Nature Aging · doi:10.1038/s43587-024-00630-2 · Cited by 42
Tajbakhsh, A., Read, M. I., Barreto, G. E., Ávila-Rodriguez, M., Hayat, S. M. G., & Sahebkar, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173873 · Cited by 41
Xing, Z., Zuo, Z., Hu, D., Zheng, X., Wang, X., Yuan, L., Zhou, L., Qi, F., & Yao, Z. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.015 · Cited by 38
Mechanistic insights into the role of herpes simplex virus 1 in Alzheimer’s disease
Feng, S., Liu, Y., Zhou, Y., Shu, Z., Cheng, Z., Brenner, C., & Feng, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1245904 · Cited by 36
Profiling TREM2 expression in amyotrophic lateral sclerosis
Jericó, I., Vicuña‐Urriza, J., Blanco‐Luquin, I., Macías, M., Martínez‐Merino, L., Roldán, M., Rojas‐García, R., Pagola, I., Carbayo, Á., de Luna, N., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.01.013 · Cited by 43
Targeting CaN/NFAT in Alzheimer’s brain degeneration
Mackiewicz, J., Lisek, M., & Boczek, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1281882 · Cited by 41
Multi-functional role of apolipoprotein E in neurodegenerative diseases
Islam, S., Noorani, A. A., Sun, Y., Michikawa, M., & Zou, K. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1535280 · Cited by 43
Chen, Y., Hong, T., Chen, F., Sun, Y., Wang, Y., & Cui, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631827 · Cited by 40
Cao, C., Ding, J., Cao, D., Li, B., Wu, J., Li, X., Li, H., Cui, G., Shen, H., & Chen, G. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105809 · Cited by 40
Synapses, Microglia, and Lipids in Alzheimer’s Disease
Paasila, P. J., Aramideh, J. A., Sutherland, G. T., & Graeber, M. B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.778822 · Cited by 40
Dynamics of phagocytosis mediated by phosphatidylserine
Vorselen, D. (2022) · Biochemical Society Transactions · doi:10.1042/bst20211254 · Cited by 39
Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Singh, M. K., Shin, Y., Ju, S., Han, S., Kim, S. S., & Kang, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136901 · Cited by 43
Jiang, W., Liu, F., Li, H., Wang, K., Cao, X., Xu, X., Zhou, Y., Zou, J., Zhang, X., & Cui, X. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.04.005 · Cited by 38
INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model
Iguchi, A., Takatori, S., Kimura, S., Muneto, H., Wang, K., Etani, H., Ito, G., Sato, H., Hori, Y., Sasaki, J., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106375 · Cited by 37
Zhou, H., Li, J., Hu, L., Yu, J., Fu, X., Liang, F., Yan, F., & Chen, G. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.03.011 · Cited by 36
Metabolomic and lipidomic signatures in autosomal dominant and late‐onset Alzheimer's disease brains
Novotny, B. C., Fernández, M. V., Wang, C., Budde, J., Bergmann, K., Eteleeb, A. M., Bradley, J. L., Webster, C., Ebl, C., Norton, J. B., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12800 · Cited by 42
TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice
Xie, X., Zhang, W., Xiao, M., Wei, T., Qiu, Y., Qiu, J., Wang, H., Qiu, Z., Zhang, S., Pan, Y., et al. (2023) · Blood · doi:10.1182/blood.2022018619 · Cited by 34
The emerging double-edged sword role of exosomes in Alzheimer’s disease
Liang, T., Wu, Z., Li, J., Wu, S., Shi, W., & Wang, L. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1209115 · Cited by 37
Zhang, N., Ji, Q., Chen, Y., Wen, X., & Shan, F. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06579-9 · Cited by 40
Lloyd, A. F., Martínez‐Muriana, A., Davis, E., Daniels, M. J. D., Hou, P., Mancuso, R., Brenes, A. J., Sinclair, L. V., Geric, I., Snellinx, A., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114908 · Cited by 47
Alzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link
Hu, J., & Wang, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.811852 · Cited by 42
The dense-core plaques of Alzheimer’s disease are granulomas
Lemke, G., & Huang, Y. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20212477 · Cited by 37
Ma, C., Wu, Y., Song, L., Yin, L., Yin, J.-J., Wang, Q., Yu, J., & Xiao, B. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.355747 · Cited by 37
The Vascular-Immune Hypothesis of Alzheimer’s Disease
Mehta, R. I., & Mehta, R. I. (2023) · Biomedicines · doi:10.3390/biomedicines11020408 · Cited by 39
Biophysical modeling with variational autoencoders for bimodal, single-cell RNA sequencing data
Carilli, M., Gorin, G., Choi, Y., Chari, T., & Pachter, L. S. (2024) · Nature Methods · doi:10.1038/s41592-024-02365-9 · Cited by 33
Zhang, S.-S., Gao, Z., Feng, L., & Li, M. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s483412 · Cited by 39
Zhou, L., Lu, Y., Qiu, X., Chen, Z., Tang, Y., Meng, Z., Yan, C., Du, H., Li, S., & Lin, J. D. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115310 · Cited by 41
Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
Biber, K., Bhattacharya, A., Campbell, B. M., Piro, J. R., Rohe, M., Staal, R. G. W., Talanian, R. V., & Möller, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00840 · Cited by 39
Meprin β cleaves TREM2 and controls its phagocytic activity on macrophages
Berner, D. K., Wessolowski, L., Armbrust, F., Schneppenheim, J., Schlepckow, K., Koudelka, T., Scharfenberg, F., Lucius, R., Tholey, A., Kleinberger, G., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902183r · Cited by 39
Microglial TREM2 at the Intersection of Brain Aging and Alzheimer’s Disease
Qu, W., & Li, L. (2021) · The Neuroscientist · doi:10.1177/10738584211040786 · Cited by 38
Targeting TREM2 for Parkinson’s Disease: Where to Go?
Li, X., & Zhang, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.795036 · Cited by 38
Regulation of microglia phagocytosis and potential involvement of exercise
Li, C., Wang, Y., Xing, Y., Han, J., Zhang, Y., Zhang, A., Hu, J., Hua, Y., & Bai, Y. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.953534 · Cited by 37
Neurodegenerative fluid biomarkers are enriched in human cervical lymph nodes
Al‐Diwani, A., Provine, N. M., Murchison, A. G., Laban, R., Swann, O., Koychev, I. G., Sheerin, F., Mesquita, S. D., Heslegrave, A., Zetterberg, H., et al. (2024) · Brain · doi:10.1093/brain/awae329 · Cited by 38
The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention
Merlo, S., Spampinato, S. F., Caruso, G. I., & Sortino, M. A. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200131105418 · Cited by 35
García‐León, J. A., Cáceres-Palomo, L., Sánchez‐Mejías, E., Mejias‐Ortega, M., Nuñez‐Diaz, C., Fernandez-Valenzuela, J. J., Sanchez-Varo, R. M., Dávila, J. C., Vitórica, J., & Gutiérrez, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186867 · Cited by 35
Wang, C., Gao, W.-R., Yin, J., Wang, Z.-J., Qi, J., Cai, H.-Y., & Wu, M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113400 · Cited by 38
Gerring, Z. F., Gamazon, E. R., White, A. R., & Derks, E. M. (2021) · Neurology Genetics · doi:10.1212/nxg.0000000000000622 · Cited by 36
Pang, X., Chu, Y., Zhou, L., Chen, M., You, Y., Tang, Y., Yang, S., Zhang, H., Xiao, J., Deng, G., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15987 · Cited by 33
Large-scale neurophysiology and single-cell profiling in human neuroscience
Lee, A. T., Chang, E. F., Paredes, M. F., & Nowakowski, T. J. (2024) · Nature · doi:10.1038/s41586-024-07405-0 · Cited by 35
Konishi, H., & Kiyama, H. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104878 · Cited by 33
Yang, S., Yang, Y., Wang, F., Luo, Q., Zhang, Y., Zheng, F., Shu, Q., Chen, Q., & Fang, X. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0521oc · Cited by 35
Microglia in Alzheimer’s Disease: An Unprecedented Opportunity as Prospective Drug Target
Kulkarni, B., Martins, N. A., & Kumar, D. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02661-x · Cited by 38
Taming microglia: the promise of engineered microglia in treating neurological diseases
Luo, E. Y., & Sugimura, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03015-9 · Cited by 35
Metadata
- Authors
- Ulland, T. K., & Colonna, M.
- Affiliations
- University of Wisconsin–Madison (US)
- Washington University in St. Louis (US)
- Corresponding author
- Colonna, Marco
- Venue
- Nature Reviews Neurology
- Published
- 2018-09-28
- Volume
- 14
- Issue
- 11
- Pages
- 667-675
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W2894203109
- Semantic Scholar
- ee2227720d29d3e454a2aa0cfa8d9df4c32b869a
- Cited by
- 735
- References
- 123
- Citations by year
- 2026: 102 · 2025: 115 · 2024: 119 · 2023: 100 · 2022: 117 · 2021: 89 · 2020: 60 · 2019: 29 · 2018: 3
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREM2, Alzheimer's disease, microglia, disease-associated microglia, amyloid plaques, neuroinflammation, late-onset Alzheimer's disease, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Humans, Membrane Glycoproteins, Mutation, Receptors, Immunologic, Amyloid beta-Protein Precursor, Microglia, Presenilins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
